Received Mar 18, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | 1 | Unknown | PO / MO |
The patient was throwing up quite profusely; Case reference number US-BN-2025-000988 is a spontaneous case initially received from consumer via Communication (reference number: USBAV25-1236) on 27-May-2025 and concerns 17-years-old female patient. The patient's medical history and concomitant medication details were not provided. On 25-May-2025, the patient took the first dose of Vivotif (batch number: unknown) at dose of four capsule, orally, for indication for pre travel. On the same date, as reported maybe hour and a half after taking first dose, the patient ended up throwing up quite profusely. At the time of the initial report, the patient did not recover from the event 'vomiting', reported as ongoing. The reporter assessed event of 'vomiting' as non-serious and did not provide causality assessment due to Vivotif vaccine. No further information was provided.; Reporter's Comments: This case concerns a 17-year-old female patient who experienced non-serious event of vomiting on the same date and an hour and half after first dose of Vivotif vaccine for indication for pre travel. Vomiting is listed per CCDS V8 and expected per USPI. At the time of the initial report, the patient did not recover from the event 'vomiting', reported as ongoing. The patient's medical history and concomitant medication details were not provided. Based on the limited information provided regarding this case, the causal role of the suspect vaccine cannot be excluded in the occurrence of the event, with the same day latency, the event is considered related to the suspect vaccine. This case is considered as non-serious.; Sender's Comments: This case concerns a 17-year-old female patient who experienced non-serious event of vomiting on the same date and an hour and half after first dose of Vivotif vaccine for indication for pre travel. Vomiting is listed per CCDS V8 and expected per USPI. At the time of the initial report, the patient did not recover from the event 'vomiting', reported as ongoing. The patient's medical history and concomitant medication details were not provided. Based on the limited information provided regarding this case, the causal role of the suspect vaccine cannot be excluded in the occurrence of the event, with the same day latency, the event is considered related to the suspect vaccine. This case is considered as non-serious. USBAV25-1236:
Comments: None.